Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole

BACKGROUND: The pharmacokinetics and pharmacodynamics of a novel orally disintegrating tablet (ODT) formulation of delayed-release dexlansoprazole 30 mg was evaluated versus the dexlansoprazole 30 mg capsule in this phase I, open-label, multiple-dose, randomized, two-period crossover study. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076779/
https://www.ncbi.nlm.nih.gov/pubmed/27803731
http://dx.doi.org/10.1177/1756283X16670073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076779/
https://www.ncbi.nlm.nih.gov/pubmed/27803731
http://dx.doi.org/10.1177/1756283X16670073

Ejemplares similares